Skip to main content
Back to 5Y Capital

5Y Capital's Biotechnology Portfolio

Browse 23 Biotechnology companies funded by 5Y Capital. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
23
Total Funding in Biotechnology
$949.2M

Biotechnology Portfolio Companies (23)

Export
BiotechnologyHealth CareMedical

LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.

San Francisco, United States
May 2026
$40.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyPharmaceutical

Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness.

Laguna Hills, United States
April 2026
$23.4M
Series A

Founder Contacts

19,000+ verified contacts

Alternative MedicineArtificial Intelligence (AI)BiotechnologyGeneticsTherapeutics

ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.

Brisbane, United States
April 2026
Corporate Round

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife Science

Hopewell Therapeutics is a Synthetic Lipid-based drug delivery company for gene therapy and gene editing.

Woburn, United States
September 2025
$2.5M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyTherapeutics

Signet Therapeutics is a cutting-edge firm that conducts research and development on cancer-targeted drugs.

Shenzhen, China
January 2026
$11.5M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceutical

Zenitar is a biomedical technology company engaged in innovative drug research and industrialization processes.

Chengdu, China
January 2026
$86.0M
Series C

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceutical

Allink Biotherapeutics is a biopharmaceutical company that develops multi-specific antibodies for oncology and immunology treatment.

Shanghai, China
December 2025
$47.0M
Series A

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Biotechnology

Syneron is a company that using artificial intelligence and biotechnology to address two significant global challenges.

Guangzhou, China
December 2025
$100.0M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceuticalProduct ResearchTherapeutics

Minghui Pharmaceutical is a biopharmaceutical business that specializes in immunology and oncology medicines for unmet needs.

Shanghai, China
August 2025
$131.0M
Series Unknown

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiopharmaBiotechnologyMedical DevicePharmaceutical

METiS Pharmaceuticals is the world's first AI-driven drug formulation company.

Hangzhou, China
August 2025
$55.7M
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth DiagnosticsTherapeutics

Simaixu Biotechnology is a biopharmaceutical firm that develop small molecule drugs for cancer, and chronic diseases with new technologies

Suzhou, China
July 2025
$1.6M
Series Unknown

Founder Contacts

19,000+ verified contacts

Biotechnology

Accro Bioscience research centers on the molecular mechanism of regulated cell death such as necroptosis, pyroptosis, and ferroptosis.

Suzhou, China
March 2025
$13.8M
Series B

Founder Contacts

19,000+ verified contacts

Advanced MaterialsBiotechnologyChemicalChemical EngineeringManufacturing

Zhongke Guosheng is research and development firm that designs and manufactures furan-based bio-based materials.

Hangzhou, China
March 2025
$27.6M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyGeneticsHealth CareMachine Learning

METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.

Cambridge, United States
April 2022
$75.0M
Series B

Founder Contacts

19,000+ verified contacts

AgTechBiotechnologyGeneticsTest and Measurement

Igenesis is a biotechnology company that provides molecular diagnostic technologies.

Shanghai, China
March 2022
$15.8M
Series C

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CarePharmaceutical

Regenerative Bio is the world's first anti-aging biotechnology company driven by artificial intelligence and cloud supercomputing.

Cambridge, United States
February 2022
$10.0M
Angel

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyMedicalPharmaceutical

Xbiome is a developer of microbial pharmaceuticals designed to treat microecological intestinal disorders.

Shenzhen, China
December 2021
$100.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Redesign Science is a computational chemistry company setting a new standard for early-stage, small molecule drug discovery.

New York, United States
December 2021
$15.0M
Seed

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareProduct Research

NeoX Biotech is a pharmaceutical company engaged in early-stage drug developmentbased on AI and computational biophysical technology.

Beijing, China
July 2021
Series A

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyCloud ComputingProduct Research

Galixir is an artificial intelligence technology to promote the research and development of new drugs.

Shenzhen, China
December 2020
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyClinical TrialsCloud ComputingMedicalPharmaceuticalSoftware

Taimei Technology provides a cloud platform for clinical research collaboration.

Jiaxing, China
September 2020
$176.2M
Series Unknown

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical

Polaris Biology is a medical technology company specializing in the development and clinical application.

Shanghai, China
June 2020
$9.9M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareInformation Technology

GeneDock is a biotechnology software company that provides cloud-based platforms for genetic data storage, analysis and collaboration.

Beijing, China
August 2018
$7.3M
Series B

Founder Contacts

19,000+ verified contacts

Explore 5Y Capital's Full Portfolio

View all companies funded by 5Y Capital across every industry and funding stage.

View Full 5Y Capital Portfolio